Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

被引:158
作者
Przedborski, S
Chen, QP
Vila, M
Giasson, BI
Djaldatti, R
Vukosavic, S
Souza, JM
Jackson-Lewis, V
Lee, VMY
Ischiropoulos, H
机构
[1] Columbia Univ, Dept Neurol, Neurosci Res Movement Disorder Div, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[3] Childrens Hosp Philadelphia, Stokes Res Inst, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
[5] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
dopaminergic neurons; MPTP; neurodegeneration; Parkinson's disease; substantia nigra; synuclein;
D O I
10.1046/j.1471-4159.2001.00174.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural and functional alterations of alpha -synuclein is a presumed culprit in the demise of dopaminergic neurons in Parkinson's disease (PD), alpha -Synuclein mutations are found in familial but not in sporadic PD, raising the hypothesis that effects similar to those of familial PD-linked alpha -synuclein mutations may be achieved by oxidative post-translational modifications. Here, we show that wild-type alpha -synuclein is a selective target for nitration following peroxynitrite exposure of stably transfected HEK293 cells. Nitration of alpha -synuclein also occurs in the mouse striatum and Ventral midbrain following administration of the parkinsonian neurotoxin 1-methyt-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Conversely, beta -synuclein and synaptophysin were not nitrated in MPTP-intoxicated mice. Our data demonstrate that alpha -synuclein is a target for tyrosine nitration, which, by disrupting its biophysical properties, may be relevant to the putative role of alpha -synuclein in the neurodegeneration associated with MPTP toxicity and with PD.
引用
收藏
页码:637 / 640
页数:4
相关论文
共 50 条
  • [41] Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson's Disease
    Tristao, Fabrine S. M.
    Amar, Majid
    Latrous, Ines
    Del-Bel, Elaine A.
    Prediger, Rui D.
    Raisman-Vozari, Rita
    NEUROTOXICITY RESEARCH, 2014, 25 (01) : 24 - 32
  • [42] Mulberrin attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease by promoting Wnt/β-catenin signaling pathway
    Cao, Wenhui
    Dong, Yan
    Zhao, Weina
    Lu, Xin
    Sun, Li
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 98 : 63 - 70
  • [43] Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson’s Disease
    Feng Lai
    Rong Jiang
    Wenjun Xie
    Xinrong Liu
    Yong Tang
    Hong Xiao
    Jieying Gao
    Yan Jia
    Qunhua Bai
    Neurochemical Research, 2018, 43 : 1986 - 1999
  • [44] THEAFLAVIN AMELIORATES BEHAVIORAL DEFICITS, BIOCHEMICAL INDICES AND MONOAMINE TRANSPORTERS EXPRESSION AGAINST SUBACUTE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-INDUCED MOUSE MODEL OF PARKINSON'S DISEASE
    Anandhan, A.
    Janakiraman, U.
    Manivasagam, T.
    NEUROSCIENCE, 2012, 218 : 257 - 267
  • [45] Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease
    Lai, Feng
    Jiang, Rong
    Xie, Wenjun
    Liu, Xinrong
    Tang, Yong
    Xiao, Hong
    Gao, Jieying
    Jia, Yan
    Bai, Qunhua
    NEUROCHEMICAL RESEARCH, 2018, 43 (10) : 1986 - 1999
  • [46] The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mice myocardial morphology
    Sasahara, Tais H. C.
    Machado, Marcia R. F.
    PESQUISA VETERINARIA BRASILEIRA, 2019, 39 (05): : 364 - 370
  • [47] Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice
    Turmel, H
    Hartmann, A
    Parain, K
    Douhou, A
    Srinivasan, A
    Agid, Y
    Hirsch, EC
    MOVEMENT DISORDERS, 2001, 16 (02) : 185 - 189
  • [48] Inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse
    Kurkowska-Jastrzebska, I
    Wronska, A
    Kohutnicka, M
    Czlonkowski, A
    Czlonkowska, A
    EXPERIMENTAL NEUROLOGY, 1999, 156 (01) : 50 - 61
  • [49] Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice
    Lu, Edward
    Sarkar, Sumit
    Raymick, James
    Paule, Merle G.
    Gu, Qiang
    BRAIN RESEARCH, 2018, 1678 : 432 - 439
  • [50] Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease
    Khan, Mohammad Moshahid
    Hoda, Md Nasrul
    Ishrat, Tauheed
    Ahmad, Ajmal
    Khan, Mohammad Badruzzaman
    Khuwaja, Gulrana
    Raza, Syed Shadab
    Safhi, Mohammed M.
    Islam, Fakhrul
    BEHAVIOURAL PHARMACOLOGY, 2010, 21 (5-6): : 563 - 571